Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Gynecological Oncology

This article is part of the Research TopicAdvances in Diagnosis and Treatment of Endometrial CancerView all 16 articles

Omentectomy for Apparent Early-stage Uterine Serous Carcinoma: a Large Retrospective Cohort Study

Provisionally accepted
Ouling  ZhangOuling Zhang1Yuedong  HeYuedong He2Ai  ZhengAi Zheng2Yu  XuYu Xu2*
  • 1Sichuan University West China Second University Hospital, Chengdu, China
  • 2West China Second University Hospital, Sichuan University, Chengdu, China

The final, formatted version of the article will be published soon.

Objectives: This study aims to compare the effects of different omental assessment methods (omentectomy and omental biopsy) on the long-term prognosis of apparent early-stage uterine serous cancer (USC). Methods: In the retrospective cohort study, a total of 255 women with clinical early-stage USC were included. They were divided into the omentectomy group and the omental biopsy group. The Kaplan-Meier method and the log-rank test were employed to estimate and compare overall survival and disease-free survival between groups. The Cox proportional hazards regression model was used to adjust for potential confounding factors. Results: When compared with undergoing omentectomy, women with apparent early-stage USC who underwent omental biopsy had a deteriorated 5-year OS (HR: 1.76, 95% CI: 1.07-3.52, P=0.009) and 5-year DFS (HR: 1.72, 95% CI: 1.15-2.86, 删除了: A 2 / 12 P=0.012). After adjusting for confounding factors, omental biopsy was independently associated with worsening long-term prognosis in apparent early-stage USC (For DFS, aHR=1.78, 95% CI: 1.13-3.20, P=0.025; For OS, aHR=1.68, 95% CI: 1.11-2.75, P=0.041). Conclusions: For apparent early-stage USC, in terms of long-term survival outcomes, omentectomy is superior to omental biopsy.

Keywords: uterine serous carcinoma, Omentectomy, overall survival, Disease-freesurvival, endometrial cancer

Received: 30 Jun 2025; Accepted: 14 Nov 2025.

Copyright: © 2025 Zhang, He, Zheng and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yu Xu, xuyu_obgy@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.